IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GIUSTINA, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.759
EU - Europa 6.242
AS - Asia 4.438
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 18
SA - Sud America 11
AF - Africa 8
Totale 29.496
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.714
UA - Ucraina 2.559
CN - Cina 2.338
DE - Germania 950
SG - Singapore 858
PL - Polonia 742
HK - Hong Kong 662
FI - Finlandia 512
FR - Francia 377
IE - Irlanda 364
TR - Turchia 335
GB - Regno Unito 300
IT - Italia 290
IN - India 151
CA - Canada 44
RU - Federazione Russa 36
SE - Svezia 33
VN - Vietnam 28
BE - Belgio 25
IR - Iran 25
CZ - Repubblica Ceca 22
EU - Europa 20
AU - Australia 18
NL - Olanda 13
ID - Indonesia 8
JP - Giappone 8
BR - Brasile 7
SA - Arabia Saudita 6
MU - Mauritius 4
RO - Romania 4
ES - Italia 3
PK - Pakistan 3
TW - Taiwan 3
BD - Bangladesh 2
CL - Cile 2
CM - Camerun 2
DK - Danimarca 2
EC - Ecuador 2
EE - Estonia 2
KR - Corea 2
MA - Marocco 2
MY - Malesia 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CY - Cipro 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
MX - Messico 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 29.496
Salva come PNG Salva come JPEG
Città #
Fairfield 3.211
Woodbridge 2.445
Houston 1.739
Jacksonville 1.739
Ashburn 1.434
Cambridge 1.303
Ann Arbor 1.282
Seattle 1.212
Wilmington 1.110
Warsaw 741
Princeton 689
Hong Kong 654
Singapore 644
Nanjing 636
Chandler 515
Dublin 364
Beijing 320
Istanbul 292
Nanchang 256
New York 222
Helsinki 186
Des Moines 181
Shenyang 163
Changsha 135
San Diego 130
Hebei 127
Jiaxing 109
Tianjin 104
Milan 89
Kunming 69
Jinan 68
Shanghai 59
Brescia 55
Dearborn 49
Hangzhou 47
Verona 47
Lancaster 40
San Mateo 37
Lanzhou 36
Kocaeli 35
Haikou 32
Los Angeles 30
Ningbo 29
Boardman 28
Dong Ket 28
Leawood 28
San Francisco 28
Toronto 28
Zhengzhou 25
Brussels 24
Augusta 22
Taizhou 22
Brno 20
Guangzhou 20
Ardabil 18
Changchun 16
London 16
Washington 16
Orange 14
Munich 12
Taiyuan 12
Monmouth Junction 11
Norwalk 11
Redwood City 11
Fuzhou 9
Kilburn 9
Mumbai 9
Ottawa 9
Cassina de' Pecchi 8
Melbourne 8
Tokyo 8
Jakarta 7
Greifswald 6
Nürnberg 6
Phoenix 6
Pune 6
Romola 6
Canberra 5
Central 5
New Bedfont 5
Riyadh 5
Auburn Hills 4
Bangalore 4
Falkenstein 4
Hefei 4
Santa Clara 4
Sydney 4
Ariano nel Polesine 3
Bergamo 3
Bologna 3
Brockton 3
Cleveland 3
Dallas 3
Falls Church 3
Hanover 3
Hendon 3
Islington 3
Napoli 3
Sabz 3
São Paulo 3
Totale 23.255
Salva come PNG Salva come JPEG
Nome #
Elevated intraocular pressure in patients with acromegaly 272
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 247
Ghrelin regulates proliferation and differentiation of osteoblastic cells 203
Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients. 198
Guidelines for acromegaly management. 186
Bone ultrasonometric features and grow hormone secretion in asthmatic patients during chronic inhaled corticosteroid therapy 148
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 148
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines 147
Role of stroma in haemoglobin synthesis: experiments on duck red cells in vitro. 144
A retrospective hormonal and immunohistochemical evaluation of 47 acromegalic patients: prognostic value of preoperative plasma prolactin. 139
Growth hormone deficiency in treated acromegaly 135
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 132
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 132
Effects of pyridostigmine on spontaneous and growth hormone-releasing hormone stimulated growth hormone secretion in children on daily glucocorticoid therapy after liver transplantation. 129
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 129
Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy 128
Growth, insulin-like growth factor I (IGF-I), and IGF-binding proteins 1 and 3 in children with severe liver disease before and after liver transplantation: a longitudinal and cross-sectional study 127
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 124
Role of AMP-Activated Protein Kinase Activators in Antiproliferative Multi-Drug Pituitary Tumour Therapies: Effects of Combined Treatments with Compounds Affecting the mTOR-p70S6 Kinase Axis in Cultured Pituitary Tumour Cells 124
Acromegalic patients show the presence of hypertrophic remodeling of subcutaneous small resistance arteries. 120
Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. 120
The management of the patient with acromegaly and headache: a still open clinical challenge. 118
Long-term Picotamide, a dual thromboxane inhibitor, decreases urinary albumin excreation rate in type 2 diabetic patients with microalbuminuria at rest. 116
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 116
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 116
Pituitary testing: a reappraisal. 115
Dehydroepiandrosterone sulfate enhances natural killer cell cytotoxicity in humans via locally generated immunoreactive insulin-like growth factor I. 114
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 113
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 113
Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. 112
Development of a meningioma in a patient with acromegaly during octreotide treatment: are there any causal relationships? 112
Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women. 112
Sleep apnoea syndrome is highly prevalent in acromegaly and only partially reversible after biochemical control of the disease. 111
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 111
Chronic glucocorticoid treatment alters spontaneous pulsatile parathyroid hormone secretory dynamics in human subjects. 110
A single dose of aztreonam in the prevention of urinary tract infections in elderly catheterized patients. 110
A consensus on criteria for cure of acromegaly. 109
Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing hormone in man. 108
Short-term effect of captopril and nifedipine on micro-albuminuria induced by exercise in hypertensive diabetic patients. 108
Development of isolated ACTH deficiency in a man with type I diabetes mellitus. 108
Type 2 diabetes mellitus is associated with faster degeneration of bioprosthetic valve: results from a propensity score-matched italian multicenter study. 107
Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly. 107
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 107
Effects of AMPK activation and combined treatment with AMPK activators and somatostatin on hormone secretion and cell growth in cultured GH-secreting pituitary tumor cells 107
Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals 107
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 107
Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects. 106
Effects of pasireotide (SOM230) on protein turnover and p70S6 kinase-S6 ribosomal protein signaling pathway in rat skeletal muscle cells 104
Guidelines for acromegaly management: an update. 103
Effect of galanin on growth hormone (GH) response to thyrotropin releasing hormone of rat pituitary GH-secreting adenomatous cells (GH1) in culture. 102
Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. 102
New oral anticoagulants and pituitary apoplexy 102
High prevalence of radiological vertebral fractures in HIV-infected males 101
Glucocorticoids and the regulation of growth hormone secretion. 101
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 101
Influence of diabetes mellitus on vertebral fractures in men with acromegaly. 100
Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion. 100
Octreotide for acromegaly treatment: a reappraisal. 100
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 100
Acute effects of clonidine and growth-hormone-releasing hormone on growth hormone secretion in patients with hyperthyroidism. 99
TREATMENT OF GLUCOCORTICOID-INDUCED OSTEOPOROSIS. 99
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 98
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 98
Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. 98
Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man. 98
Low-dose octreotide is able to cause a maximal inhibition of the glycemic responses to a mixed meal in obese type 2 diabetic patients treated with insulin. 98
Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits. 98
Hexarelin, a novel GHRP-6 analog, stimulates growth hormone (GH) release in a GH-secreting rat cell line (GH1) insensitive to GH-releasing hormone. 98
Cardiovascular risk in aging and obesity: is there a role for GH. 98
Glucocorticoid inhibition of growth in rats: partial reversal with the full length ghrelin analog BIM-28125 97
Effects of the selective estrogen receptor modulator LY117018 on growth hormone secretion: in vitro studies. 97
Growth hormone in glucocorticoid-induced osteoporosis. 97
Effects of metoclopramide on the growth hormone response to galanin in normal man. 97
Expert consensus document:A consensus on the medical treatment of acromegaly 97
TREATMENT OF HYPOTHYROIDISM:ALL THAT GLITTERS IS GOLD? 97
Vertebral fractures in males with prolactinoma. 97
Prevalence of vertebral fractures in men with acromegaly 96
Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. 96
CORTISOL AND THE MUSCLE-BONE AXIS:RESPONSE TO COMMENTS BY MOLFINO ET AL. 96
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 96
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 95
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 95
Pituitary gland: Medical therapy for acromegaly: can we predict response? 95
A consensus on criteria for cure acromegaly 95
New understanding and treatments for osteoporosis. 95
Effect of age on beta-cell response to exogenous glucagon in man. 95
Treatment of Cushing disease: overview and recent findings. 95
Does growth hormone replacement therapy improve cardiac function? 94
Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly. 94
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial 94
SAGIT(®): clinician-reported outcome instrument for managing acromegaly in clinical practice-development and results from a pilot study 94
Ectopic secretion of growth hormone-releasing hormone (GHRH) in neuroendocrine tumors: relevant clinical aspects. 93
Growth hormone deficiency in the adult. 93
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 93
AMP-activated protein kinase regulates normal rat somatotroph cell function and growth of rat pituitary adenomatous cell 93
Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies. 93
Effect of galanin on the growth hormone response to growth hormone-releasing hormone in acromegaly. 93
Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection. 93
BONE AND JOINT DISORDERS IN ACROMEGALY. 93
Current management practices for acromegaly: an international survey. 93
Totale 11.251
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.453
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.880 0 0 0 0 570 954 807 1.029 688 1.018 293 521
2020/20215.237 88 621 123 608 225 619 210 679 729 519 643 173
2021/20222.426 136 492 35 109 12 147 98 159 117 358 209 554
2022/20231.774 387 48 10 94 150 568 2 143 234 15 58 65
2023/20241.984 107 38 92 158 91 287 112 42 670 24 14 349
2024/20251.204 15 14 18 605 552 0 0 0 0 0 0 0
Totale 29.778